Arginine vasopressin-binding peptides derived from the bovine and rat genomes differ in their abilities to block arginine vasopressin modulation of murine immune function.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Neuroimmunology

• Publication date

  1990-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0165-5728(90)90069-YPMID 2110184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Receptor-specific antibodies by immunization with "antisense" peptides?

  1989cited by this paper
• Interaction of putative vasopressin receptor proteins of rat brain and bovine pituitary gland with an antibody against a nanopeptide encoded by the reverse message of the complementary mRNA to vasopressin.

  1989cited by this paper
• Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA.

  1988cited by this paper
• Insulin-binding peptide. Design and characterization.

  1988cited by this paper
• A novel arginine vasopressin-binding peptide that blocks arginine vasopressin modulation of immune function.

  1988cited by this paper
• Ligand receptor characteristics of peptides encoded by complementary nucleic acids: implications for a molecular recognition code.

  1988cited by this paper
• Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-gamma production. Evidence for a novel AVP receptor on mouse lymphocytes.

  1988cited by this paper
• Anti-sense peptide recognition of sense peptides: direct quantitative characterization with the ribonuclease S-peptide system using analytical high-performance affinity chromatography.

  1987cited by this paper
• Role of arginine vasopressin in regulation of systemic arterial pressure.

  1986cited by this paper
• Possible recognition of the GnRH receptor by an antiserum against a peptide encoded by nucleotide sequence complementary to mRNA of a GnRH precursor peptide.

  1986cited by this paper
• Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA.

  1986cited by this paper
• Binding of peptides that are specified by complementary RNAs.

  1986cited by this paper
• Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review.

  1986cited by this paper
• Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA.

  1985cited by this paper
• Regulation of lymphokine production by arginine vasopressin and oxytocin: modulation of lymphocyte function by neurohypophyseal hormones.

  1985cited by this paper
• Recent gene conversion involving bovine vasopressin and oxytocin precursor genes suggested by nucleotide sequence

  1984cited by this paper
• Structure and comparison of the oxytocin and vasopressin genes from rat.

  1984cited by this paper
• Vasopressin and central integrative processes.

  1984cited by this paper
• Hydropathic anti-complementarity of amino acids based on the genetic code.

  1984cited by this paper
• Is vasopressin-stimulated inositol lipid breakdown intrinsic to the mechanism of Ca2+-mobilization at V1 vasopressin receptors?

  1983cited by this paper
• Vasopressin replacement of interleukin 2 requirement in gamma interferon production: lymphokine activity of a neuroendocrine hormone.

  1982cited by this paper
• Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays.

  1981cited by this paper
• Classification of interferons with antibody to immune interferon.

  1980cited by this paper
• Use of glutaraldehyde as a coupling agent for proteins and peptides.

  1980cited by this paper
• [8] Use of glutaraldehyde as a coupling agent for proteins and peptides

  1980cited by this paper
• Neurophypophysial hormones.

  1961cited by this paper

• Neuroimmune Regulation in Health: Acute Febrile Illness and Healing

  2016cites this paper
• Neuroimmune Regulation in Immunocompetence, Acute Illness, and Healing

  2009cites this paper
• The problem of amino acid complementarity and antisense peptides.

  2004cites this paper
• Neuropeptides in the immune system: functional roles in health and disease.

  2002cites this paper
• De Novo Design of Peptides Targeted to the EF Hands of Calmodulin*

  2000cites this paper
• A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help

  2000cites this paper
• On the evolution of ligands: did peptides functionally precede metals and small organic molecules?

  1999cites this paper
• Vasopressin is located within lymphocytes in the rat spleen.

  1995cites this paper
• Complementary Peptides: Applications of the Molecular Recognition Theory to Peptide and Protein Purification and Design

  1994cites this paper
• Antisense-designed peptides: a comparative study focusing on possible complements to angiotensin II.

  1994cites this paper
• Contents of corticotropin-releasing hormone and arginine vasopressin immunoreactivity in the spleen and thymus during a chronic inflammatory stress.

  1994cites this paper
• Canine parietal cell binding by antibodies to the complementary peptide of somatostatin.

  1993cites this paper
• Lack of interaction of vasopressin with its antisense peptides: a functional and immunological study.

  1993cites this paper
• Neuroendocrine peptide receptors on cells of the immune system.

  1992cites this paper
• Steroidogenic activity of a peptide specified by the reversed sequence of corticotropin mRNA.

  1990cites this paper